The DZHK research platform: Maximisation of scientific value by enabling access to health data and biological samples collected in cardiovascular clinical studies.
The German Centre for Cardiovascular Research (DZHK) is one of the German Centres for Health Research and aims to conduct early and guideline-relevant studies to develop new therapies and diagnostics that impact the lives of people with cardiovascular disease. Therefore, DZHK members designed a collaboratively organised and integrated research platform connecting all sites and partners. The overarching objectives of the research platform are the standardisation of prospective data and biological sample collections among all studies and the development of a sustainable centrally standardised storage in compliance with general legal regulations and the FAIR principles. The main elements of the DZHK infrastructure are web-based and central units for data management, LIMS, IDMS, and transfer office, embedded in a framework consisting of the DZHK Use and Access Policy, and the Ethics and Data Protection Concept. This framework is characterised by a modular design allowing a high standardisation across all studies. For studies that require even tighter criteria additional quality levels are defined. In addition, the Public Open Data strategy is an important focus of DZHK. The DZHK operates as one legal entity holding all rights of data and biological sample usage, according to the DZHK Use and Access Policy. All DZHK studies collect a basic set of data and biosamples, accompanied by specific clinical and imaging data and biobanking. The DZHK infrastructure was constructed by scientists with the focus on the needs of scientists conducting clinical studies. Through this, the DZHK enables the interdisciplinary and multiple use of data and biological samples by scientists inside and outside the DZHK. So far, 27 DZHK studies recruited well over 11,200 participants suffering from major cardiovascular disorders such as myocardial infarction or heart failure. Currently, data and samples of five DZHK studies of the DZHK Heart Bank can be applied for.
SchlagwörterCardiovascular Disease ; Data And Biomaterial Collection ; German Centre For Cardiovascular Research ; Research Platform ; Standardisation; Risk Postinfarction Patients; Translational Registry; Ejection Fraction; Management; Rationale; Design
FörderungenDiasys medpoint GmbH MDI Limbach Sysmex Deutsche Akkreditierungsstelle German Research Foundation German National Cohort German Society for Clinical Chemistry and Laboratory Medicine German Centre for Cardiovascular Research German Medical Association Projekt DEAL AstraZeneca Novartis Boehringer Ingelheim DFG Medtronic European Union BMBF DZHK Governments of the Federal States Federal Ministry of Research and Education Pharmacosmos Daiichi-Sankyo Adrenomed AG Else Kroner-Fresenius-Stiftung (Else Kroner Clinician Scientist Professorship) German Center for Neurodegenerative Diseases German Ministry of Research and Education Neosoft Ltd. Bayer Healthcare Bayer Amgen Abbott Aerocom GmbH Vifor Pharma German Center for Cardiovascular Research German Ministry of Education and Research EU (Horizon2020) Boston Scientific Abbott Vascular Vifor Fondation Leducq Roche Diagnostics LabNet Laborsysteme GmbH Profil Institut fur Stoffwechselforschung GmbH ZS Pharma